In this report

With the number of cases predicted to reach 592m worldwide by 2013, tackling the condition will require redoubled attention on effective treatments, broader diagnosis and more intense prevention

Diabetes sufferers seek injection of effort

As the number of cases and treatment costs rise inexorably, World Diabetes Day is a reminder that there is much more to do

Drug manufacturers seek to expand the range of treatments

Potential makers of insulin are withdrawing to develop in other areas and leaving it to the big three

scientists at the Danish Stem Cell Centre have found a way to grow a miniature pancreas from mouse progenitor cells
©University of Copenhagen

Research: Biological ways to achieve the correct levels

Progress is being made in creating insulin-producing cells

Special report

Byron Classic Burger Byron Burgers
Another FT special report, The Future of the Food Industry, is to be published on Wednesday November 20

Mechanical solution to type 1 diabetes in sight

Hormone regulators linked to smartphones are on the way

Prevention:Carrots and sticks approach wins mixed reviews

Health schemes face an uphill battle in an era of junk food and drink

Steps to help people live with diabetes

Healthcare systems need to adapt to manage long-term conditions

Universal availability of insulin yet to be achieved

Distribution is still unequal around the world

Extra care needs to be taken during Ramadan

Diabetics are not required to fast, but many want to do so


Mexico: The land that gave us corn and chocolate has an obesity epidemic

Government aims to stop rise in diabetes within two years

Australia: Aboriginals are still seven times more likely to die of diabetes

Governments have neglected to address inequities


Unhealthy developments as burden of disease shifts

With poor medical provision and no visible signs of a cure, World Diabetes Day offers scant cause for celebration, writes Andrew Jack

Drugs: Research may find route to repairing the sick pancreas

Although insulin is still the primary tool to control blood sugar, new treatments may delay complications, says Alan Rappeport

Complications: Foot ulcers, eye problems and worse

Alan Rappeport reviews progress in dealing with nerve damage

Foot ulcer drug: Cuba seeks breakthrough

The communist country has high hopes for Heberprot-P, writes Andrew Jack

Post-marketing trials: Debate simmers

When conducted well, it can provide valuable additional information on safety and efficacy, writes Andrew Jack

Diagnostics: Testing times in race to identify sufferers

The technology is improving but misconceptions are the big problem, says Denise Roland

Remote monitoring: Apps hold promise to improve care and cut costs

The ubiquity of mobile phones can be used for health, says Sarah Murray

Science: Deeper inquiry begins to shed light on causes

While diet and lifestyle affect the prevalence of type 2 diabetes, there are intriguing genetic factors, writes Clive Cookson

Food and drink: Battle to keep lawmakers sweet as sugary drinks targeted

Nutrition is a battleground between producers, consumer groups and health professionals, writes Louise Lucas

India: Education aims to cure ignorance

Incidence of diabetes is spreading faster than awareness of it, writes Amy Kazmin

US: Size of problem requires mass awareness-raising

Tackling the disease will be crucial for the economy as well as sufferers, writes Sarah Murray